Agenus Inc.
General ticker "AGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $91.6M (TTM average)
Agenus Inc. follows the US Stock Market performance with the rate: 43.6%.
Estimated limits based on current volatility of 2.8%: low 4.07$, high 4.31$
Factors to consider:
- Total employees count: 162 as of 2000
- US accounted for 0.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Inability to obtain additional financing, High development costs, Labor/talent shortage/retention, Regulatory and compliance, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.12$, 6.99$]
- 2025-12-31 to 2026-12-31 estimated range: [1.79$, 5.67$]
Financial Metrics affecting the AGEN estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -267.88 <= 0.33
- Positive: Investing cash flow per share per price, % of 0.05 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -0.02 <= 0
Short-term AGEN quotes
Long-term AGEN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $98.84MM | $156.87MM | $107.42MM |
| Operating Expenses | $278.27MM | $316.42MM | $227.89MM |
| Operating Income | $-179.43MM | $-159.55MM | $-120.47MM |
| Non-Operating Income | $-51.23MM | $-97.89MM | $-111.80MM |
| Interest Expense | $61.86MM | $97.92MM | $117.63MM |
| R&D Expense | $186.69MM | $234.57MM | $155.53MM |
| Income(Loss) | $-230.66MM | $-257.44MM | $-232.27MM |
| Profit(Loss)* | $-220.07MM | $-245.76MM | $-227.21MM |
| Stockholders Equity | $-61.28MM | $-160.33MM | $-326.38MM |
| Inventory | $13.83MM | $0.00MM | $0.00MM |
| Assets | $413.56MM | $313.91MM | $226.27MM |
| Operating Cash Flow | $-175.37MM | $-224.20MM | $-158.31MM |
| Capital expenditure | $53.06MM | $9.95MM | $0.58MM |
| Investing Cash Flow | $-33.61MM | $3.40MM | $0.03MM |
| Financing Cash Flow | $95.83MM | $119.87MM | $122.84MM |
| Earnings Per Share** | $-15.62 | $-13.73 | $-10.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.